Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET
Company Participants
Dave Doherty – Chief Financial Officer
Wayne DeVeydt – Executive Chairman
Eric Evans – Chief Executive Officer
Conference Call Participants
Jack Slevin – Jefferies
Joanna Gajuk – Bank of America
A.J. Rice – UBS
Andrew Mok – Barclays
Tao Qiu – Stifel
Sarah James – Cantor Fitzgerald
Bill Sutherland – The Benchmark Company
Benjamin Rossi – JPMorgan
Will Spivack – TD Cowen
Operator
Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
At this time, I would like to turn the call over to Dave Doherty. Please go ahead.
Dave Doherty
Good morning. My name is Dave Doherty, CFO of Surgery Partners. I’m joined today by Eric Evans, our CEO; and Wayne DeVeydt, our Executive Chairman. During this call, we will make forward-looking statements. There are risk factors that could cause future results to be materially different from these statements.
These risk factors are described in this morning’s press release and the reports we file with the SEC, each of which are available on our website, surgerypartners.com. The company does not undertake any duty to update these forward-looking statements.
In addition, we will reference certain financial measures that are considered non-GAAP, which we believe can be useful in evaluating our performance. The presentation of this information should not be considered in isolation or as a substitute for results prepared in accordance with GAAP. These measures are reconciled to the most applicable GAAP measure in this morning’s press release.
With that, I will turn the call over to Wayne. Wayne?
Wayne DeVeydt
Thank you, Dave. Good morning, and thank you all for joining us today.
Before turning the call over to
Read the full article here
